Aldeyra Therapeutics's total assets for Q3 2025 were $77.80T, an increase of 91570483.15% from the previous quarter. DE:137 total liabilities were $28.56T for the fiscal quarter, a 96231453.25% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.